Brief: China Nt Pharma Group Says Restructuring Of Suzhou First Pharma
21/08/2023 16:17
Aug 21 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* RESTRUCTURING OF SUZHOU FIRST PHARMA
* EQUITY TRANSFER DEAL ENTERED BETWEEN NT (CHINA)
INVESTMENT,
KIMFORD INVESTMENT, JIANGSU ZHENGJI PHARMACY, SUZHOU FIRST
PHARMA
Source text for Eikon: ID:nHKS71VkQX
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY